Zelira Therapeutics signs deed to acquire Health House International April 18, 2022 SYDNEY, AUSTRALIA: Zelira Therapeutics Ltd (ASX:ZLD) has executed a binding scheme implementation deed to acquire 100% of Health House International Limited (ASX: HHI) via…
ECS Botanics secures $4.5 million medicinal cannabis supply agreement with Alivio Spolka July 25, 2021 SYDNEY, AUSTRALIA: ECS Botanics Holdings has entered into a five year agreement with Polish company Alivio Spolka ZO. for the supply of medicinal cannabis…
Kanabo signs medicinal cannabis production agreement March 9, 2021 LONDON: Kanabo Group (LON: KNB) has signed a production and supply agreement with PharmaCann Polska under which PharmaCann will supply cartridges containing Kanabo’s proprietary…
Wellfully joins forces with Dolce Cann Global on medicinal cannabis product development December 21, 2020 SYDNEY: Wellfully Limited will engage in collaboration with NSW-based Dolce Cann Global Ltd Pty to develop cannabinoid products using its patented drug delivery system….
Sativa Group gets Controlled Drug Licence October 16, 2019 LONDON: Sativa Group’s wholly owned subsidiary Sativa Cultivation and Extraction Ltd, has been awarded a Controlled Drug licence for cannabis (with THC content of…